Two of the many associations examined reached nominal significance in a protective direction: myocardial infarction (HR 0.84, P-trend 0.02) and the composite outcome within the prevalent-CVD subgroup (HR 0.81). Three considerations discount each as a real effect.
First, multiplicity: numerous endpoints (composite, total/CV/non-CV mortality, major CVD, MI, stroke, heart failure) and several subgroups were tested, so a few nominally significant results are expected under a true null.
Second, non-replication: neither signal appears in the independent ONTARGET/TRANSCEND cohorts - MI HR there is 1.12 (0.68-1.82) and there is no protective subgroup effect - whereas a genuine effect of this magnitude should show some concordance across the paper’s own cohorts.
Third, internal inconsistency: the prevalent-CVD subgroup interaction is itself non-significant (P=0.24), so the stratum-specific difference is within sampling noise, and secondary-prevention patients in ONTARGET/TRANSCEND (a comparable high-risk group) show no such protection.
Together these make chance a more parsimonious explanation than an endpoint- or subgroup-specific protective effect, which is why the authors urge caution; the inference caps the weight these isolated protective signals should carry and supports the overall neutral reading.
Validity verdict (step 6)
status: approved, checked. Reconstruction: hidden load-bearing premise is that under a true null, testing many endpoints/subgroups is expected to throw up a few nominally significant results, so nominal significance without concordance is weak evidence of a real effect. Conditional on the premises (multiplicity, non-replication in ONTARGET/TRANSCEND, non-significant P=0.24 interaction), the step to “chance is the more parsimonious reading” is a standard evidential inference and traces cleanly. Undercutting-defeater probe: the strongest defeater is that ONTARGET/TRANSCEND are high-risk secondary-prevention trials, so a real but population-specific effect could legitimately fail to replicate — but this does not survive as a step-breaker because (a) the conclusion is already hedged to “most likely chance / caps the weight,” not “proven null,” and (b) the multiplicity and internally non-significant subgroup interaction independently support the chance reading regardless of the cross-population issue. No weaker conclusion is forced; the as-stated probabilistic claim holds.